Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.

Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19

Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.

Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.

Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for RSV vaccines.

Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.

David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical care

Don Sin discusses a new tool for clinicians to use to detect potential exacerbations in patients with chronic obstructive pulmonary disorder.